AI assistant
EROAD Limited — Director's Dealing 2018
Mar 14, 2018
66188_rns_2018-03-14_e4f3f15d-4e6d-43e7-be7d-5ce125f24588.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [91 x 25] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:
Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:
EROAD Limited 13-Mar-18 N/A Graham Stuart EROAD Limited Not applicable Director
| Summary of acquisition or disposal of relevant interest(excluding specified | Summary of acquisition or disposal of relevant interest(excluding specified | derivatives) |
|---|---|---|
| Class of affected quoted financial products: | Ordinary Shares in EROAD Limited (ERD) |
|
| Nature of the affected relevant interest(s): | Registered holder and beneficial owner | |
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 0 | |
| Number held in class after acquisition or disposal: | 20,000 | |
Current registered holder(s): |
Graham Robert Stuart & Nicola Roberta Stuart |
|
| Registered holder(s) once transfers are registered: | Not applicable | |
| Summary of acquisition or disposal of specified derivatives relevant interest | (if applicable) | |
| Type of affected derivative: | Not applicable | |
| Class of underlying financial products: | Not applicable | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable | |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | |
| Maturity date of the derivative (if any): | Not applicable | |
| Expiry date of the derivative(if any): | Not applicable | |
| The price specified in the terms of the derivative (if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable | |
| For that derivative,- | ||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 2 |
| Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of anyotherpartyorparties to the transaction(if known): The consideration,expressed in New Zealand dollars, paid or received for the Number of financialproducts to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of duringa closed |
Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of anyotherpartyorparties to the transaction(if known): The consideration,expressed in New Zealand dollars, paid or received for the Number of financialproducts to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of duringa closed |
||
|---|---|---|---|
| Date of transaction: | 8 March 2018 | 9 March 2018 | |
| Nature of transaction: | On market purchase of 19,964 EROAD ordinary shares |
On market purchase of 36 EROAD ordinary shares |
|
| Name of anyotherpartyorparties to the transaction(if known): | Unknown | Unknown | |
| The consideration,expressed in New Zealand dollars, paid or received for the | $69,674.36 | $125.64 | |
| Number of financialproducts to which the transaction related: | 19,964 | 36 | |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
No Not applicable Not applicable |
||
| Whether relevant interests were acquired or disposed of duringa closed | No | ||
| Whether prior written clearance was provided to allow the acquisition or | Not applicable | ||
| Date of the prior written clearance (if any): | Not applicable |
Summary of other relevant interests after acquisition or disposal:
| Summary of other relevant interests after acquisition or disposal: | ||
|---|---|---|
| Class ofquoted financialproducts: | Not applicable | |
| Nature of relevant interest: | Not applicable | |
| _For that relevant interest,- _ | ||
| Number held in class: | Not applicable | |
| Current registered holder(s): | Not applicable | |
| For a derivative relevant interest,- | ||
| Type of derivative: | Not applicable | |
| Details of derivative,- | ||
| The notional value of the derivative (if any) or the notional amount of | ||
| underlying financial products (if any): | Not applicable | |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | |
| Maturity date of the derivative (if any): | Not applicable | |
| Expiry date of the derivative (if any): | Not applicable | |
| The price's specified terms (if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration | ||
| payable under the derivative or the value of the derivative is affected by the | ||
| value of the underlying financial products: | Not applicable | |
| For that derivative relevant interest,- | Not applicable | |
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of | ||
| the relevant interest in the derivative: | Not applicable | |
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
13-Mar-18 Mark Heine, EVP, General Counsel